药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
BA-2664
Timepidium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Timepidium.
BA-2664
Pipenzolate
The risk or severity of adverse effects can be increased when Revefenacin is combined with Pipenzolate.
BA-2664
Emetonium iodide
The risk or severity of adverse effects can be increased when Revefenacin is combined with Emetonium iodide.
BA-2664
Fenpiverinium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Fenpiverinium.
BA-2664
Camylofin
The risk or severity of adverse effects can be increased when Revefenacin is combined with Camylofin.
BA-2664
Diphemanil
The risk or severity of adverse effects can be increased when Revefenacin is combined with Diphemanil.
BA-2664
Penthienate
The risk or severity of adverse effects can be increased when Revefenacin is combined with Penthienate.
BA-2664
Dihexyverine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Dihexyverine.
BA-2664
Tiemonium iodide
The risk or severity of adverse effects can be increased when Revefenacin is combined with Tiemonium iodide.
BA-2664
Etanautine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Etanautine.
BA-2664
Bornaprine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Bornaprine.
BA-2664
Rociverine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Rociverine.
BA-2664
Bevonium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Bevonium.
BA-2664
Poldine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Poldine.
BA-2664
Otilonium
The risk or severity of adverse effects can be increased when Revefenacin is combined with Otilonium.
BA-2664
Etybenzatropine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Etybenzatropine.
BA-2664
Mazaticol
The risk or severity of adverse effects can be increased when Revefenacin is combined with Mazaticol.
BA-2664
Phenglutarimide
The risk or severity of adverse effects can be increased when Revefenacin is combined with Phenglutarimide.
BA-2664
Difemerine
The risk or severity of adverse effects can be increased when Revefenacin is combined with Difemerine.
BA-2664
Benzilone
The risk or severity of adverse effects can be increased when Revefenacin is combined with Benzilone.